Best Treatments for Duchenne Muscular Dystrophy

Duchenne muscular dystrophy, also known as DMD, is a genetic, progressive condition that causes loss of muscle function over time. It’s mostly seen in boys and men, but it can also occur, often in a milder form, in girls. The condition is present at birth, but symptoms typically present in early childhood. While many new treatments are on the horizon, current treatment options for Duchenne muscular dystrophy may slow the progression of the disease and treat its symptoms, but cannot halt or reverse its course.
For decades, medications called steroids have been part of the standard of care for Duchenne muscular dystrophy. While these drugs have been shown to extend muscle function, including the ability to walk, they have many unpleasant side effects.
RELATED: What Is Muscular Dystrophy?
Treating DMD means tackling all the problems that can arise from the condition, from muscle tightness to cardiovascular and breathing problems. Ideally, a multidisciplinary healthcare team will take many different approaches to ensure that all of your needs and concerns are addressed.
In some cases, there may be a treatment available that’s specific to the exact mutation causing your DMD. Current treatments may help prolong muscle function beyond what steroids can do, but so far, there’s no evidence they have a dramatic effect on the course of the disease.
Learn More About the Doctors and Other Specialists Who Treat Muscular Dystrophy
Steroid Therapy for Duchenne Muscular Dystrophy
Corticosteroids, referred to as steroids for short, are the main drug treatment for Duchenne muscular dystrophy. Among doctors who treat the condition, “we all agree that steroids are the cornerstone of Duchenne management,” says Vamshi K. Rao, MD, a pediatric neurologist and the codirector of the Muscular Dystrophy Association Clinic at Lurie Children’s Hospital in Chicago.
That’s because so far, steroids are the only treatment that has been shown to slow the course of DMD across the board. Steroid treatment has been shown to increase muscle strength, delay loss of walking ability by as much as two to three years, reduce the risk of scoliosis (sideways spinal curvature), and improve pulmonary (breathing) function in people with DMD, according to the Muscular Dystrophy Association (MDA).
Right now, there are two approved steroids for DMD: prednisone (Deltasone) and deflazacort (Emflaza). Your doctor may prescribe either a daily regimen or a high-dose weekend regimen.
Steroids tend to have the greatest benefit in Duchenne muscular dystrophy when they’re started early in life, says Leigh Maria Ramos-Platt, MD, a pediatric neurologist and the director of the Muscular Dystrophy Association Neuromuscular Clinic at Children’s Hospital Los Angeles.
“If I see a boy at 4 years of age and give him steroids, versus a boy with the same mutation at 10 and give him steroids, the boy that starts at 4 is most likely going to outwalk the boy that starts at 10,” Dr. Ramos-Platt notes.
There’s disagreement about how early in life steroid treatment can safely be started. It’s considered standard to start it by age 4 or 5, says Ramos-Platt, but starting at age 2 or 3 is more controversial. “Usually, when I can convince parents to start younger, it’s when they’ve already had a boy with Duchenne who stopped walking a lot younger than is typical, like age 7,” she notes, referring to older brothers who also have the condition. “So those are the parents who will say, let’s start at 3 rather than wait until they’re 4 or 5.”
Side effects of steroids can include weight gain, short stature, acne, mood and behavioral changes, and bone problems like osteoporosis and compression fractures. Regular spinal imaging may help identify vertebral fractures that don’t immediately cause symptoms, and is considered appropriate for DMD, according to the MDA.
Treating Heart Problems in Duchenne Muscular Dystrophy
Since the heart is a muscle, basically everyone with Duchenne muscular dystrophy develops heart problems eventually — usually by their teenage years, and sometimes before this. “Over time, what happens is that as it breaks down, it doesn’t have the capacity to pump well, and it starts to get weaker and enlarges,” says Dr. Rao.
The best, proactive approach to heart management in DMD is to start measuring heart function early, so that any changes in function are immediately known, says Rao. “That’s a proactive diagnostic approach,” he explains. “The proactive treatment approach would be to lessen the workload on the heart as it starts to get weaker.”
There are a number of drugs that can help reduce the heart’s workload, including angiotensin-converting enzyme (ACE) inhibitors and beta-blockers. The decision to start a drug treatment for heart problems in Duchenne is usually made by a cardiologist, and tends to depend on that doctor’s approach rather than absolute guidelines.
For example, “The heart doctors here are pretty aggressive. They start treatment at around age 7” for most boys with DMD, says Ramos-Platt.
Treating Breathing Problems in Duchenne Muscular Dystrophy
Over time, DMD tends to weaken the muscles that control breathing. The aim of pulmonary care for the condition is to make breathing easier and make sure your body is getting the oxygen it needs.
Pulmonary function testing is the key to proactive management of breathing issues, says Rao. This involves simply blowing into a mouthpiece in a doctor’s office, which gives a measure of lung capacity and can be used to assess the loss of function over time.
Since breathing tends to be more difficult while we sleep, if you have reduced pulmonary function due to Duchenne muscular dystrophy, your doctor may recommend a sleep study to see how your breathing changes at night. Depending on the results, your doctor may recommend a supportive treatment to help you breathe while you sleep, such as a BiPAP (bilevel positive airway pressure) machine. “If you are already using a device at night such as BiPAP,” Rao notes, a sleep study is good for “monitoring whether that BiPAP is giving you enough pressure to normalize your sleep breathing pattern.”
Another treatment option for breathing problems is a cough assist device, which helps expel mucus from your airways. “When your muscles are weak, it can make mucus stagnant and cause infection,” explains Ramos-Platt. These devices may be used in tandem with chest percussion devices, which vibrate or hit your chest to help loosen mucus.
As breathing worsens, it may be necessary to wear BiPAP for longer periods, or to start using a mechanical ventilator — which may involve a tracheostomy, in which a hole is created in your neck. This highly invasive, but sometimes life-sustaining, treatment is at one end of “a whole gradient of how we treat lung function in Duchenne,” Ramos-Platt notes.
Other Treatments for Duchenne Muscular Dystrophy
Depending on your symptoms and course of disease, any number of other treatments may be warranted for Duchenne muscular dystrophy, including the following:
Exon Skipping Drugs These drugs are designed to partially resolve certain mutations that cause it, leading to some amount of functional dystrophin protein. But only a minority of people with DMD are candidates for them, and it remains to be seen whether they lead to functional improvements.
Physical Therapy, Stretching, and Range-of-Motion Exercises Working with a physical therapist, and doing recommended stretches and exercises at home, is key to maintaining as much strength and flexibility as possible, says Rao — regardless of your disease progression or mobility status.
Scoliosis Treatments Scoliosis, or sideways spinal curvature, is a common problem in Duchenne muscular dystrophy as muscle function worsens. It’s important to monitor the progression of scoliosis both visually and by X-ray, says Rao. “As it starts to change, you start to introduce scoliosis braces or vests, of different kinds and different materials,” he notes.
Severe scoliosis sometimes warrants surgery, especially if the curvature of your spine negatively affects your heart function or breathing. But “scoliosis surgeries can be pretty involved, and sometimes the rehabilitation can be prolonged,” Rao cautions. “The risk-benefit profile needs to be individualized.”
RELATED: Your Everyday Guide to Living Well With Muscular Dystrophy

Anna C.E. Hurst, MD, MS, FACMG
Medical Reviewer
Dr. Hurst is a physician for the UAB Undiagnosed Disease program, Turner syndrome clinic, and general genetics clinic, and she provides hospital consultations for inpatients at UAB and Children’s of Alabama for general genetics and inborn errors of metabolism. She also is the medical geneticist for the Smith Family Clinic for Genomic Medicine in Huntsville, Alabama.
Hurst's research focuses on expanding the availability of genomic sequencing for children with complex healthcare needs. She also has an interest in how the patient’s physical exam and facial features can be clues to a rare disease diagnosis (dysmorphology) and serves on the scientific advisory board of Facial Dysmorphology Novel Analysis. She has published over 45 peer-reviewed articles in the field of medical genetics, largely focused on the clinical delineation of rare disease phenotypes. She also serves as an associate editor for the American Journal of Medical Genetics.
Hurst is also passionate about education and serves as the program director of the UAB genetics residency programs (categorical, pediatrics-genetics, and internal medicine-genetics) and medical director of the UAB Genetic Counseling Training program. She is an officer with the Association of Professors in Human Medical Genetics.
Quinn Phillips
Author
A freelance health writer and editor based in Wisconsin, Quinn Phillips has a degree in government from Harvard University. He writes on a variety of topics, but is especially interested in the intersection of health and public policy. Phillips has written for various publications and websites, such as Diabetes Self-Management, Practical Diabetology, and Gluten-Free Living, among others.
- Duchenne Muscular Dystrophy. Genetic and Rare Diseases Information Center. February 2023.
- Duchenne Muscular Dystrophy (DMD). Muscular Dystrophy Association.
- What Is Duchenne Muscular Dystrophy? Parent Project Muscular Dystrophy.
- Duchenne Muscular Dystrophy. National Organization for Rare Disorders. March 25, 2021.
- Duchenne Muscular Dystrophy in Children. Cedars-Sinai.
- Duchenne Muscular Dystrophy. Johns Hopkins Medicine.
- Muscular Dystrophy: Symptoms and Causes. Mayo Clinic. February 11, 2022.
- BiPAP. Johns Hopkins Medicine.
- Assisted Devices for Coughing. Parent Project Muscular Dystrophy.